These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9152226)

  • 1. Efficacy of treatment after measurable diabeticlike retinopathy in galactose-fed rats.
    Robison WG; Laver NM; Jacot JL; Chandler ML; York BM; Glover JP
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1066-73. PubMed ID: 9152226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
    Robison WG; Laver NM; Jacot JL; Glover JP
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal capillary dilation: early diabetic-like retinopathy in the galactose-fed rat model.
    Glover JP; Jacot JL; Basso MD; Hohman TC; Robison WG
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):167-72. PubMed ID: 10803427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs.
    Kador PF; Takahashi Y; Akagi Y; Neuenschwander H; Greentree W; Lackner P; Blessing K; Wyman M
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1916-21. PubMed ID: 12036999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats.
    Robison WG; Jacot JL; Glover JP; Basso MD; Hohman TC
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1933-41. PubMed ID: 9727416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galactose-induced retinal microangiopathy in rats.
    Kern TS; Engerman RL
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
    Robison WG; Nagata M; Laver N; Hohman TC; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic-like retinopathy ameliorated with the aldose reductase inhibitor WAY-121,509.
    Robinson WG; Laver NM; Jacot JL; Glover JP; Basso MD; Blouin P; Hohman TC
    Invest Ophthalmol Vis Sci; 1996 May; 37(6):1149-56. PubMed ID: 8631629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve.
    Robison WG; Nagata M; Tillis TN; Laver N; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2293-9. PubMed ID: 2509396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iris vasculopathy in galactose-fed rats.
    Caspers-Velu LE; Wadhwani KC; Rapoport SI; Kador PF
    Exp Eye Res; 1999 Feb; 68(2):211-21. PubMed ID: 10068486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldose reductase, diabetes, and thickening of the retinal inner limiting membrane.
    Nagata M; Robison WG
    Invest Ophthalmol Vis Sci; 1987 Nov; 28(11):1867-9. PubMed ID: 3117719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subnormal retinal oxygenation response precedes diabetic-like retinopathy.
    Berkowitz BA; Kowluru RA; Frank RN; Kern TS; Hohman TC; Prakash M
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2100-5. PubMed ID: 10440266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
    Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
    Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
    Frank RN; Amin R; Kennedy A; Hohman TC
    Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic-like corneal sensitivity loss in galactose-fed rats ameliorated with aldose reductase inhibitors.
    Jacot JL; Hosotani H; Glover JP; Lois N; Robison WG
    J Ocul Pharmacol Ther; 1998 Apr; 14(2):169-80. PubMed ID: 9572543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
    Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
    Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy.
    Berkowitz BA; Ito Y; Kern TS; McDonald C; Hawkins R
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2964-9. PubMed ID: 11687543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeability of the blood-retinal and blood-aqueous barriers in galactose-fed rats.
    Caspers-Velu LE; Wadhwani KC; Rapoport SI; Kador PF
    J Ocul Pharmacol Ther; 1995; 11(3):469-87. PubMed ID: 8590278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aldose reductase inhibitors and galactose withdrawal on fluorescein angiographic lesions in galactose-fed dogs.
    Cusick M; Chew EY; Ferris F; Cox TA; Chan CC; Kador PF
    Arch Ophthalmol; 2003 Dec; 121(12):1745-51. PubMed ID: 14662595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.